VYOME HOLDINGS, INC. Inventory, Supplies, Net of Reserves
VYOME HOLDINGS, INC. (HIND) had Inventory, Supplies, Net of Reserves of $911.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Raw Materials and Supplies, Net of Reserves
us-gaap:InventorySuppliesNetOfReserves · last filed 2025-08-14
- 2025-06-30: Inventory, Supplies, Net of Reserves $911.00K.
- 2025-03-31: Inventory, Supplies, Net of Reserves $1.04M.
- 2024-12-31: Inventory, Supplies, Net of Reserves $1.02M.
- 2024-09-30: Inventory, Supplies, Net of Reserves $1.16M.
| Period end | Inventory, Supplies, Net of Reserves |
|---|---|
| 2025-06-30 | $911.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.04M 10-Q · filed 2025-05-20 |
| 2024-12-31 | $1.02M 10-Q · filed 2025-08-14 |
| 2024-09-30 | $1.16M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.22M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.27M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.38M 10-K · filed 2025-04-04 |
| 2023-09-30 | $1.05M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $999.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $1.01M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $864.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $927.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.20M 10-Q · filed 2022-08-19 |
| 2022-03-31 | $1.23M 10-Q · filed 2022-05-23 |
| 2021-12-31 | $682.00K 10-K · filed 2023-04-17 |
| 2021-09-30 | $680.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $588.00K 10-Q · filed 2021-08-16 |
| 2020-12-31 | $733.00K 10-K · filed 2022-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |